Group Product Director, US Oncology Precision Medicine, RYBREVANT

Johnson & Johnson Innovative Medicine•Horsham, PA
•Onsite

About The Position

Johnson & Johnson is recruiting a Group Product Director for US Oncology Precision Medicine, with primary alignment to the lung cancer franchise and responsibility for leading precision medicine work for the RYBREVANT portfolio, including lung, colorectal cancer (CRC), and head and neck cancer. The role shapes and executes precision medicine strategies for current and future oncology brands, supporting the broader Solid Tumor and Hematology portfolios and developing oncology portfolio-level precision medicine capabilities. The position partners closely with lung and pipeline brand teams, Therapeutic Area leadership, and launch-readiness teams to align precision medicine strategies with brand priorities and disease-state, provider, and patient needs. Reporting to the Senior Director, US Oncology Precision Medicine, the role leads portfolio initiatives and collaborates with commercial, medical, policy, access, and field teams. The position is based in Horsham, Pennsylvania, and may require up to 25% domestic travel.

Requirements

  • Bachelor’s degree required.
  • At least 5 years of experience in marketing, sales, and/or Precision Medicine.
  • Prior Precision Medicine experience, either directly or through a targeted therapy product.
  • Demonstrated ability to foster a growth mindset and high performance expectations, and to create an environment of testing and learning.
  • Strong communication and collaboration skills.

Nice To Haves

  • MBA or advanced degree.
  • Experience in Oncology.
  • Commitment to learning emerging technologies such as AI through exploration, iteration, and applying new tools over time.

Responsibilities

  • Build understanding of the patient testing journey, diagnostic landscape, and testing rates at national and sub-national levels, in partnership with Commercial Excellence and brand teams.
  • Serve as the commercial subject matter expert on biomarkers and ensure alignment across brand assets, messaging, and execution.
  • Collaborate with franchise, brand, and field teams to identify and address account-level precision medicine needs aligned with strategic priorities.
  • Partner with Policy and Access teams to support broad access to guideline-concordant testing across the Janssen oncology portfolio.
  • Partner with lung and pipeline brand teams to develop and execute precision medicine strategies aligned with brand priorities.
  • Lead unbranded biomarker awareness and testing initiatives for healthcare practitioners, pathologists, and other key stakeholders.
  • Develop and maintain an integrated US Precision Medicine external communications strategy, including digital engagement and congress presence.
  • Lead portfolio initiatives to enhance precision medicine capabilities across the organization.
  • Drive disease-state-specific precision medicine strategies in partnership with cross-functional teams.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service